Cargando…

The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity

Background: Research on employee care partners of patients with multiple sclerosis (MS) is limited. Objectives: The clinical and economic impact on employee care partners was evaluated by MS disease severity. Methods: Employees with spouses/domestic partners with MS from the Workpartners database (J...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendin, Barry, Brook, Richard A., Beren, Ian A., Kleinman, Nathan, Fink, Cindy, Phillips, Amy L., Lobo, Carroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2023
Materias:	Neurological Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105615/ https://www.ncbi.nlm.nih.gov/pubmed/37069893 http://dx.doi.org/10.36469/001c.57593

Ejemplares similares

Patterns of Comorbidity and Multimorbidity Among Patients With Multiple Sclerosis in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

Disability and workers' compensation trends for employees with mental disorders and SUDs in the United States
por: Brook, Richard A., et al.
Publicado: (2021)

Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia
por: Xie, Lin, et al.
Publicado: (2013)

The Hidden Economic Consequences of Migraine to the UK Government: Burden-of-Disease Analysis Using a Fiscal Framework
por: Martins, Rui, et al.
Publicado: (2023)

The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis
por: Pardo, Gabriel, et al.
Publicado: (2022)

The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis
por: Greene, Nupur, et al.
Publicado: (2022)

Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies
por: Simoens, Steven
Publicado: (2022)

Chronic traumatic encephalopathy neuropathologic change is uncommon in men who played amateur American football
por: Iverson, Grant L., et al.
Publicado: (2023)

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)
por: Mowry, Ellen M., et al.
Publicado: (2020)

SUN-296 Acromegaly Significantly Impacts Employees’ Health Benefit Costs and Increases Work Absenteeism
por: Yuen, Kevin C j, et al.
Publicado: (2020)

Retrospective cohort study of the relationship between systolic blood pressure variability and multiple sclerosis disability
por: Goldman, Myla D, et al.
Publicado: (2020)

Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Lovett-Racke, Amy, et al.
Publicado: (2022)

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

Identifying responders and nonresponders to interferon therapy in multiple sclerosis
por: Prosperini, Luca, et al.
Publicado: (2014)

Oxidative stress in multiple sclerosis—Emerging imaging techniques
por: Hollen, Christopher, et al.
Publicado: (2023)

Dietary Therapy in Secondary Progressive Multiple Sclerosis: A Case Report
por: Nathan, Janak, et al.
Publicado: (2019)

Associative Increases in Amyotrophic Lateral Sclerosis Survival Duration With Non-invasive Ventilation Initiation and Usage Protocols
por: Khamankar, Nishad, et al.
Publicado: (2018)

Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD)
por: Shepherd, Charles, et al.
Publicado: (2017)

High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
por: Freeman, Léorah, et al.
Publicado: (2022)

Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?
por: Gombash, Sara E., et al.
Publicado: (2022)

Persistence and Adherence with Urinary Antispasmodic Medications Among Employees and the Impact of Adherence on Costs and Absenteeism
por: Kleinman, Nathan L., et al.
Publicado: (2014)

Healthcare Utilization, Costs of Care, and Mortality Among Patients With Spinal Muscular Atrophy
por: Tan, Hiangkiat, et al.
Publicado: (2019)

Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington’s Disease–associated Chorea Initiated on Tetrabenazine
por: Sung, Victor W., et al.
Publicado: (2018)

A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms
por: Duchowny, Michael S., et al.
Publicado: (2021)

Budget Impact Analysis of Treatment Flow Optimization in Epilepsy Patients: Estimating Potential Impacts with Increased Referral Rate to Specialized Care
por: Iwasaki, Masaki, et al.
Publicado: (2021)

Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease
por: Claassen, Daniel O., et al.
Publicado: (2021)

The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication
por: Frois, Christian, et al.
Publicado: (2013)

Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson’s Disease
por: Thach, Andrew, et al.
Publicado: (2021)

Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System Encounters
por: Bhatta, Madhav P., et al.
Publicado: (2021)

Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review
por: Yee, Karen S., et al.
Publicado: (2022)

Multiple Comorbidities, Psychiatric Disorders, Healthcare Resource Utilization and Costs Among Adults with Essential Tremor: A Retrospective Observational Study in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

Healthcare Utilization, Costs of Care, and Mortality Among Patients With Spinal Muscular Atrophy
por: Tan, Hiangkiat, et al.
Publicado: (2019)

Medicaid Eligibility and Time to Re-incarceration Among Previously Incarcerated Subjects With Schizophrenia
por: Kozma, Chris, et al.
Publicado: (2016)

Using Propensity Score Matching Technique to Estimate Utilization and Costs of General Practitioners’ Services associated with Alzheimer’s Disease
por: Sharma, Rajan, et al.
Publicado: (2016)

Follow-up Care among Medicaid Patients with Schizophrenia treated with Antipsychotics in the Inpatient Setting
por: Farr, Amanda M., et al.
Publicado: (2014)

Denial and Empathy: Partners in Employee Trust Repair?
por: Bagdasarov, Zhanna, et al.
Publicado: (2019)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

Structural Properties and Interaction Partners of Familial ALS-Associated SOD1 Mutants
por: Huai, Jisen, et al.
Publicado: (2019)

Impact of involving people with dementia and their care partners in research: a qualitative study
por: Miah, Jahanara, et al.
Publicado: (2020)

Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey
por: Rinker, John R, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l528f3cfa6qdnq8sp0lpq5tc7o